Actinium Pharmaceuticals, Inc.

ATNM · AMEX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$53,391$59,928$65,325$72,904
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$975$1,101$0$357
Total Curr. Assets$54,366$61,029$66,456$74,506
Property Plant & Equip (Net)$1,453$1,659$1,864$2,069
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$329$327$324
Tax Assets$0$0$0$0
Other NC Assets$332$0$0$0
Total NC Assets$1,785$1,988$2,191$2,393
Other Assets$0$0$0$0
Total Assets$56,151$63,017$68,647$76,899
Liabilities
Payables$0$7,714$6,520$7,568
Short-Term Debt$610$600$0$0
Tax Payable$0$0$0$0
Deferred Revenue$35,000$0$0$0
Other Curr. Liab.-$28,776$0$0$0
Total Curr. Liab.$6,834$8,314$7,110$8,148
LT Debt$533$0$0$0
Deferred Rev, NC$0$35,000$35,000$35,000
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$35,000$0$0$0
Total NC Liab.$35,533$35,690$35,843$35,993
Other Liabilities$0$0$0$0
Cap. Leases$1,143$0$1,433$1,573
Total Liabilities$42,367$44,004$42,953$44,141
Equity
Pref Stock$0$0$0$0
Common Stock$31$31$31$31
Retained Earnings-$403,773-$398,642-$391,764-$375,826
AOCI$0$0$0$0
Other Equity$417,526$0$0$0
Total Equity$13,784$19,013$25,694$32,758
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$56,151$63,017$68,647$76,899
Net Debt-$52,248-$59,328-$65,325-$72,904
Actinium Pharmaceuticals, Inc. (ATNM) Financial Statements & Key Stats | AlphaPilot